HungaroTrial
Type: Clinical Research Organizations
Last updated: 2010-02-10
HungaroTrial (HT) is a phase 2-4 CRO in CEE. HT knows that the #1 reason trials fail is poor patient enrollment. In the past 10 years, HT completed recruitment objectives 100% of the time. In each competitive recruitment trial, HT recruits more patients than projected. For a US sponsor, HT exceeded recruitment by 61% and rescued the study. In another trial, HT enrolled 222 patients – 23.3% more than the requested 180 patients, making up for the shortfall at other sites and saving the study.
Region(s):
Europe
Services:
- Clinical Research Organizations
- Phase
- II & III
- IV
- Therapeutic Specialty
- Cardiology/Vascular Diseases
- Endocrinology
- Oncology
- Gastroenterology
- Hematology
- Immunology/Infectious Diseases
- Psychiatry/Psychology
- Musculoskeletal
- Pulmonary/Respiratory Diseases
- Nephrology/Urology
- Rheumatology
- Neurology
- Medical Devices
- Pain Management
- Vaccines
- Pediatrics/Neonatology
- Pharmacology/Toxicology
- Men's Health
- Services
- Clinical Pharmacology
- Clinical Trial Monitoring
- Clinical Trial Management
- Project Management
- Quality Assurance
- Phase





